The American Cancer Society is hosting live workshops about how patients' quality of life is improved when the palliative care conversation starts early.
Advances in targeted therapy for pediatric patients were presented at the AACR Special Conference on Pediatric Cancer.
New research into molecular subtyping for breast cancer reveals that traditional tests may yield false-positive results.
Cell-based immunotherapy may offer new therapy options for patients with metastatic RCC.
Studies presented at the 15th World Conference on Lung Cancer reveal two new approaches to improving outcome in advanced-stage lung cancer.
This patient, who had an increasing PSA level, was found to have abnormal PCA3 urine test results.
A 65-year-old male patient with a high PSA level and a bone scan showing new lesions requires a recommendation for the next treatment step.
A woman with Stage III breast cancer who is about to undergo adjuvant chemotherapy needs a recommendation to maintain her bone health.
This CME activity from ASCO 2012 reviews the results of the ongoing PACE (Ponatinib Ph+ ALL and CML Evaluation) trial.
This CME activity from ASCO 2012 reviews crizotinib in patients with ALK-positive non-small cell lung cancer.
Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.
Married patients less likely to present with metastatic disease, die from their cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|